Infomedia Ltd (ASX:IFM)

Verve Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	77.93	70.44	64.86	69.05	66.8	103.92
Cash & Short-Term Investments	77.93	70.44	64.86	69.05	66.8	103.92
Cash Growth	19.96%	8.61%	-6.06%	3.37%	-35.72%	568.98%
Accounts Receivable	15.62	18.75	16.12	12.31	11.47	11.54
Other Receivables	1.08	1.63	1.2	1.75	2.57	0.52
Receivables	16.7	20.38	17.31	14.06	14.04	12.06
Prepaid Expenses	3.93	2.49	2.33	2.95	4.05	2.34
Other Current Assets	-	-	-	-	2.66	-
Total Current Assets	98.56	93.32	84.5	86.05	87.54	118.31
Property, Plant & Equipment	8.59	9.88	13.39	8.41	11.33	6.05
Goodwill	21.43	20.97	20.97	20.7	20.14	17.46
Other Intangible Assets	3.56	5.54	9.85	14.96	19.39	5.86
Long-Term Accounts Receivable	-	0.12	0.57	0.91	0.71	-
Long-Term Deferred Tax Assets	7.75	7.01	4.8	2.52	0.35	-
Long-Term Deferred Charges	42.13	44.91	48.47	51.11	51.08	44.58
Other Long-Term Assets	0.33	0.32	3.11	6.25	5.32	-
Total Assets	182.35	182.07	185.66	190.91	195.86	192.26
Accounts Payable	11.11	8.38	6.87	5.56	5.13	4.14
Accrued Expenses	7.66	11.94	8.09	15.07	9.66	7.53
Current Portion of Long-Term Debt	-	-	-	-	-	0.1
Current Portion of Leases	2.39	2.43	2.47	2.15	2.67	1.89
Current Income Taxes Payable	1.12	2.34	1.79	0.36	0.36	3.5
Current Unearned Revenue	5.56	5.17	5.59	2.62	2.7	1.52
Other Current Liabilities	0.44	0.03	0.03	0.68	-	1.67
Total Current Liabilities	28.28	30.29	24.83	26.43	20.51	20.36
Long-Term Debt	-	-	-	-	-	0.74
Long-Term Leases	4.94	5.95	9.73	4.11	5.91	3.14
Long-Term Unearned Revenue	-	0.01	0.04	0.04	0.71	-
Long-Term Deferred Tax Liabilities	8.51	9.06	10.78	11.91	13.7	10.82
Other Long-Term Liabilities	1.04	1.38	1.34	0.84	1.43	2.55
Total Liabilities	43.41	47.3	47.2	44.35	42.7	37.96
Common Stock	105.2	105.2	105.2	105.2	105.2	103.19
Retained Earnings	25.68	24.93	27.33	37.14	47.32	47.47
Comprehensive Income & Other	8.06	4.64	5.93	4.23	0.64	3.65
Shareholders' Equity	138.93	134.77	138.45	146.56	153.15	154.3
Total Liabilities & Equity	182.35	182.07	185.66	190.91	195.86	192.26
Total Debt	7.33	8.37	12.2	6.25	8.58	5.87
Net Cash (Debt)	70.6	62.07	52.66	62.79	58.22	98.05
Net Cash Growth	26.73%	17.87%	-16.13%	7.85%	-40.62%	531.18%
Net Cash Per Share	0.19	0.16	0.14	0.17	0.16	0.30
Filing Date Shares Outstanding	374.72	374.63	374.95	375.56	375.76	374.46
Total Common Shares Outstanding	374.72	374.63	374.95	375.56	375.76	374.46
Working Capital	70.29	63.03	59.67	59.62	67.03	97.95
Book Value Per Share	0.37	0.36	0.37	0.39	0.41	0.41
Tangible Book Value	113.95	108.26	107.64	110.9	113.62	130.99
Tangible Book Value Per Share	0.30	0.29	0.29	0.30	0.30	0.35

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.